6-Lung Tumors Flashcards

1
Q

what is the epidemiology of lung cancer?

A
  • -Incidence: second most common carcinoma ; leading cause of cancer death (worldwide)
  • -Peak incidence: 50–70 years
  • -Sex: ♂ > ♀ (∼ 3:1)
  • -Adenocarcinoma is an exception: ♂ < ♀ (∼ 1:6)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the classification of malignant lung tumors?

A
1)primary
•Epithelial (>95%)
•Non-epithelial
2)Metastatic
–Colon
–Breast
–Renal cell carcinoma
–Prostate
–Melanoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the classification of benign lung tumors?

A
–	Commonest is hamartoma
–	Papilloma
–	Adenoma
–	Chondroma
–	Haemangioma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the hamartoma?

A

A benign mass composed of mature cells that are native to the tissue of origin but have abnormal tissue organization. Has a low potential to undergo malignant transformation.
• A tumor composed of a mixture of cartilage, fat, blood vessels, fibrous tissue, and epithelium
• Usually an incidental finding on CXR as coin lesion
• Management:
– Biopsy: benign
– PET scan: cold on PET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

hamartomas are cold or hot on PET scan?

A

cold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hamartomas are composed of…

A

mixture of cartilage, fat, blood vessels, fibrous tissue, and epithelium
often contains hair, teeth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the malignant lung tumors?

A
Primary epithelial malignancies
1)Non-small cell carcinoma
•	Adenocarcinoma
•	Squamous cell carcinoma
•	Large cell carcinoma
•	NSCLC, Nos
2)Neuroendocrine carcinoma
•	Small cell carcinoma
•	Large cell neuroendocrine carcinoma
•	Carcinoid tumor (typical and atypical)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the lung neuroendocrine tumors?

A
  • -Small cell carcinoma
  • -Large cell neuroendocrine carcinoma
  • -Carcinoid tumor (typical and atypical)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the neuroendocrine tumors?

A

A tumor derived from neuroendocrine cells (i.e., cells that receive neuronal input and release hormonal output). Examples include carcinoid tumor, pheochromocytoma, pancreatic islet cell tumors (e.g., insulinomas, glucagonomas, VIPomas), and small cell lung cancer. Typically positive for synaptophysin, chromogranin A, and neuron-specific enolase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the risk factors of lung cancer?

A
  • -Nicotine: smoking causes approx. 90% of lung cancers
  • -Occupational and environmental exposure to carcinogens: passive smoking, asbestos, arsenic, radon, uranium (SCLC)
  • -Family history (genetic predisposition)
  • -Scar tissue in the lungs (e.g., pulmonary fibrosis, history of tuberculosis)–SCC
  • -Idiopathic: particularly adenocarcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the lepidic pattern of adenocarcinoma?

A
  • -The distinct growth pattern of bronchoalveolar carcinomas is now referred to as “lepidic”. However, many clinicians and literature sources continue to use the term bronchioloalveolar carcinoma.
  • -Lepidic pattern is defined as a tumor composed of neoplastic cells lining the alveolar lining with no architectural disruption/complexity, and no lymphovascular and/or pleural invasion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the histologic subtypes of adenocarcinoma?

A

–Lepidic pattern is defined as a tumor composed of neoplastic cells lining the alveolar lining with no architectural disruption/complexity, and no lymphovascular and/or pleural invasion
–Acinar pattern is characterized by glandular formation
Papillary pattern displays true fibrovascular cores lined by tumor cells replacing the alveolar lining
–Psammoma bodies may be present
–Micropapillary is composed of ill-defined projection/tufting with no fibrovascular cores
–Solid pattern is defined as solid sheets and nests of tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the incidence of lung cancer in Ireland?

A
  • Approximately 2000 cases diagnosed / year
  • M>F; although rising incidence in females
  • Accounts for 13% of cancer deaths in men, 7% in women.
  • 1708 deaths in 2010 from lung cancer vs 634 from breast cancer
  • Lung cancer causes more deaths per year than breast, prostate and colon cancers combined
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

lang cancer commonly arises from lung parenchyma. True/False

A

False!!!!!!!!!!!!!
Lung cancer is also known as
BRONCHOGENIC CANCER (Bronchial cancer)
Often arises from major bronchi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the usual presentation of lung cancer?

A
  • Depends on Site of the primary tumour and Stage of Disease
  • Local
  • Intrathoracic
  • Distant metastases
  • Non-metastatic manifestations
  • Asymptomatic - chest x-ray
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the local effects of lung cancer?

A
•	Mass surrounding main bronchus
•	Mucosa ulcerated, roughened or nodular
•	Cough
•	Haemoptysis
•	Pleural / mediastinal involvement
–	Pneumothorax
–	Pleural effusion
•	Recurrent pneumonia distal to obstructing tumour
–	Carcinoma narrows lumen of bronchus ->
–	obstruction -> retention of secretions ->
–	infection ->
–	pneumonia -> abscess formation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the signs of the spread of lung cancer?

A
  • Intrathoracic spread to hilar and mediastinal lymph nodes

* Superior mediastinal obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

define SCLC

A
  • -strong correlation with cigarette smoking
  • -Pulmonary neuroendocrine tumor; associated with several paraneoplastic syndromes (Paraneoplastic syndromes are particularly common in SCLC because the cells originate from the diffuse neuroendocrine system (DNES) and may release substances, such as hormones and antibodies.)
  • -Very aggressive ; early metastases
  • -Associated mutations: l-myc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

define lung adenocarcinoma

A
  • -Most common type of lung cancer overall and in women
  • -Most common lung cancer in non-smokers
  • -Associated mutations: EGFR , ALK , and KRAS
  • -Distant metastases are common
  • -Noninvasive subtype: bronchioloalveolar carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

define SCC of lung

A
  • -strong association with smoking!
  • -Cavitary lesions are common
  • -Direct spread to hilar lymph nodes
  • -↑ Parathyroid hormone-related protein (PTHrP) leads to hypercalcemia (See Hypercalcemia of malignancy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are the central vs peripheral lung tumors?

A

SCLC and SCC vs adenocarinoma and large cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the Pancoast tumor?

A

A peripheral lung carcinoma (predominantly non-small cell lung cancer) located in the superior sulcus of the lung. Can compress local structures, including the recurrent laryngeal nerve (causes hoarseness), the stellate ganglion (causes Horner syndrome), the superior vena cava (causes superior vena cava syndrome), the brachiocephalic vein (causes brachiocephalic syndrome), and the brachial plexus (causes sensorimotor deficits).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is the Horner syndrome?

A

A neurologic disorder that causes a triad of miosis (an abnormally small pupil), partial ptosis (drooping of the upper eyelid), and facial anhidrosis (absence of sweating). Caused by lesions that interrupt the sympathetic nervous supply (stellate ganglion). Most cases are idiopathic, but etiologies include brainstem stroke, carotid dissection, and neoplasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what are the sites of distant metastases of lung cancer?

A
•	Lymph nodes
–	axilla, cervical, other
•	Bone
–	Pathological fracture, pain
•	Liver
•	Brain
–	Seizures, stroke, headache
•	Adrenal gland
•	Skin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what are the non-metastatic manifestations of lung cancer?

A

• Cachexia - late symptom
– Weight loss, anorexia
• Clubbing of fingers
• Paraneoplastic syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what is a paraneoplastic syndrome?

A

A set of clinical features that are caused by either an altered immune response to a systemic malignancy or by substances produced by tumors (e.g., hormones, cellular proteins).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

paraneoplastic syndrome is mediated by?

A

– Cross reacting antibodies
– Production of physiologically active factors
– Interference with normal metabolic pathways
– Idiopathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what are the paraneoplastic syndromes that are associated with both SCLC and NSCLC of the lung?

A
  • -General paraneoplastic manifestations: cachexia, increased risk of thrombosis (and lung embolism!)
  • -Dermatomyositis
  • -Acanthosis nigricans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what are the paraneoplastic syndromes that are associated with NSCLC of the lung?

A

1) Endocrine
- -Hypercalcemia of malignancy (squamous cell carcinoma)
- -Gynecomastia (large cell carcinoma)
2) Other
- -Hypertrophic osteoarthropathy (also known as Pierre-Marie-Bamberger disease)
- -Clubbing of the fingers and toes (Hippocratic fingers)
- -Swelling and pain in joints and long bones (Caused by painful arthropathy and ossifying periostitis of the distal diaphysis of long bones)
- -Hypercoagulability and thrombophlebitis migrans (adenocarcinoma)
- -Nonbacterial verrucous endocarditis (adenocarcinoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what are the paraneoplastic syndromes that are associated with SCLC of the lung?

A

1) Endocrine
- -Cushing syndrome
- -Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
2) Neurologic
- -Lambert-Eaton syndrome (similar clinical features as myasthenia gravis)
- -Paraneoplastic cerebellar degeneration
- -Peripheral neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what is the hypercalcemia of malignancy?

A

A paraneoplastic syndrome in which parathyroid hormone-related peptide (PTHrP) is secreted by the tumor. Like PTH, PTHrP causes osteoclastic bone resorption, increases serum calcium levels, and decreases renal phosphate reabsorption. Hypercalcemia, in turn, suppresses the secretion of PTH from parathyroid glands (secondary hypoparathyroidism).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

gynecomastia as a paraneoplastic syndrome is seen with which lung cancer?

A

large cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what is the Pierre-Marie-Bamberger disease?

A

Hypertrophic osteoarthropathy
syndrome characterized by clubbing and painful joint swelling (periostitis). Associated with a variety of conditions, most commonly non-small cell lung cancer (paraneoplastic syndrome). Can also arise independently of an accompanying disease (primary).

34
Q

what are lung cancer investigations?

A
•	Radiology
–	CXR
–	CT thorax
–	PET scan
•	Bloods
–	FBC, Calcium, LFT’s, U&amp;E
•	Bronchoscopy
–	Washings / lavage / biopsy if endobronchial
•	Tissue sampling
–	CT guided biopsy
–	EBUS TBNA (Endobronchial ultrasound-guided transbronchial needle aspiration)
–	CT guided biopsy of a metastasis
35
Q

what is the gold-standard in the diagnosis of lung cancer?

A
Tissue sampling
•	The gold standard for diagnosis
•	Essential for management
•	The main discriminator for management is small cell carcinoma vs nonsmall cell carcinoma
•	Small cell carcinoma is staged as
–	Limited
–	Extensive
•	Treatment is non-surgical, with chemotherapy and prophylactic cranial irradiation
36
Q

how tissue sampling is done to diagnose lung cancer?

A
•	Sputum
•	Bronchoscopic samples
–	Washings
–	Lavage
–	Biopsy
•	EBUS TBNA
–	Mediastinal nodes
–	Mass lesion
•	CT guided aspiration of the mass
•	Pleural fluid aspirate
•	Radiologically guided lesion of a metastasis
–	Liver, bone, lymph node, etc
37
Q

adenocarcinoma is peripheral or central?

A

usually peripheral

38
Q

how does adenocarcinoma grow? fast or slow

A

• Slow growing:
• Atypical adenomatous hyperplasia (AAH)- >adenocarinoma in situ (AIS) -> invasive adenocarcinoma
Tumor volume doubling time of 180–300 days

39
Q

adenocarcinoma is TTF + or -?

A

TTF+
Thyroid transcription factor, also called thyroid specific enhancer binding protein
–Distinguish primary (TTF1+) vs. metastatic (usually TTF1-) lung carcinoma
–Distinguish pulmonary adenocarcinoma (TTF1+) from squamous cell carcinoma (usually TTF1-)
–Pleural lung carcinoma (TTF1+) vs. mesothelioma (TTF1-)
–Pulmonary small cell carcinoma (TTF1+) vs. Merkel cell carcinoma (TTF1-)

40
Q

what is the most common lung cancer is nonsmokers?

A

adenocarcinoma
The association between smoking and adenocarcinoma is rising, which is attributed to increasing amounts of nitrosamines in cigarettes. These are known to primarily cause adenocarcinoma.

41
Q

what are the mutations associated with adenocarcinoma?

A

Associated mutations: EGFR , ALK , and KRAS

  • -Epidermal growth factor receptor; the mutation is found in approx. 15% of adenocarcinomas in the US.
  • -Anaplastic lymphoma kinase translocation; found in approx. 4% of adenocarcinomas in the US.
  • -KRAS: a proto-oncogene that encodes a GTPase (a ras protein) that regulates cellular growth. Mutation is associated with colon, lung, and pancreatic cancers.
42
Q

how does the adenocarcinoma look of CT?

A

ground glass appearance
A ground-glass density nodule (GGN) is a circumscribed area of increased pulmonary attenuation with preservation of the bronchial and vascular margins. A GGN can be:
–partly solid (part of the ground-glass opacity completely obscures the parenchyma)
–non-solid (no completely obscured areas) - pure ground glass nodules

43
Q

what are the causes of ground glass appearance of lungs on CT?

A

1) malignancy
- -primary (e.g., bronchoalveolar carcinoma (BAC), adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma)
2) metastases: occasionally can manifest as ground glass density nodules
3) atypical adenomatous hyperplasia
4) focal interstitial fibrosis
5) aspergillosis
6) focal pulmonary hemorrhages

44
Q

describe SCC of lung

A
  • More common centrally (major bronchi)
  • Stepwise progression:
  • Squamous metaplasia-> dysplasia -> carcinoma in situ -> invasive squamous cell carcinoma
  • Well / moderately / poorly differentiated
  • Keratin production
  • Necrosis and cavitation common
  • Intercellular bridges
  • Positive with CK5/6 and p63 immunohistochemical markers
45
Q

SCC of the lung is usually central or peripheral?

A

central

46
Q

how SCC of lung progress?

A

Squamous metaplasia-> dysplasia -> carcinoma in situ -> invasive squamous cell carcinoma

47
Q

SCC of lung produces what?

A

Keratin production

48
Q

what are the characteristic gross and microscopic appearances of SCC of the lung?

A
  • Necrosis and cavitation common

* Intercellular bridges

49
Q

SCC of the lung is commonly positive to what immunohistochemical markers?

A

• Positive with CK5/6 and p63 immunohistochemical markers

Immunohistochemistry: expression of cytokeratin subtypes CK5 and CK6

50
Q

what paraneoplastic syndrome is commonly caused by SCC of the lung?

A

humoral hypercalcemia of the lung

51
Q

what is the cytokeratin?

A

A family of intracytoplasmic intermediate filaments that make up the cellular cytoskeleton. Found predominantly in epithelial cells and thus is used in histochemical staining to identify neoplasms of epithelial origin.

52
Q

what sare the microscopic characteristics of lung adenocarcinoma?

A

Glandular tumor
–Mucin-producing cells (positive mucin staining)
–Subtypes of adenocarcinomas are classified according to the growth pattern (e.g., lepidic, papillary, acinar, solid)
The lepidic pattern of growth refers to the noninvasive spread of cancer cells along the alveolar septa that appears as alveolar wall “thickening”.

53
Q

what are the ith identifiable targets of adenocarcinoma predominant subtype

A
–	EGFR mutations
–	ALK
–	ROS-1
–	RET
–	B-RAF
54
Q

what is the programmed death-ligand 1 (PD-L1)

A

A transmembrane protein that plays a role in suppressing the immune system.
• The binding of PD-L1 to PD-1 transmits an inhibitory signal which reduces the proliferation of CD8+ T cells
• Upregulation of PD-L1 may allow cancers to evade the host immune system
• Thus many PD-L1 inhibitors are being developed as immuno-oncology therapies
• Current testing is through immunohistochemistry on tumour cells for PD-L1

55
Q

examples of monoclonal antibodies against PD-1?

A

durvalumab, avelumab, atezolizumab

56
Q

what are the neuroendocrine carcinomas?

A
•	2015 WHO Classification
–	Small cell carcinoma
•	Combined SCLC
–	Large cell neuroendocrine carcinoma
•	Combined LCNEC
–	Carcinoid tumours
•	Typical
•	Atypical
57
Q

what is the crizotinib?

A

An antineoplastic drug that belongs to the class of tyrosine kinase inhibitors. Blocks the activity of the tyrosine kinases ALK, ROS1, and MET. Used to treat ALK-positive, advanced-stage non-small cell lung cancer (NSCLC) and ROS1-positive, metastatic NSCLC.

58
Q

describe SCLC

A
  • Small to medium sized cells
  • Nuclear molding
  • Granular chromatin
  • Scant cytoplasm
  • Chromatin streaking (“crush artefact”)
  • Necrosis and prominent mitoses
  • Neuroendocrine markers (synaptophysin and chromogranin positive)
  • May get combined tumours: small cell carcinoma with squamous cell carcinoma or adenocarcinoma
59
Q

what are the pathohistological characteristics of SCLC?

A
  • -Kulchitsky cells: Small, dark blue neuroendocrine cells with hyperchromatic nuclei and scarce cytoplasm.
  • -Hyperchromatic nuclei (salt and pepper appearance) is a marker for rapid growth and high metabolic activity
  • -Rapid growth pattern
  • -Immunohistochemistry: expression of chromogranin A, neuron-specific enolase, synaptophysin, CK18, and CK7
60
Q

SCLC cancer expresses what markers?

A

Immunohistochemistry: expression of chromogranin A, neuron-specific enolase, synaptophysin, CK18, and CK7

61
Q

why paraneoplastic syndromes are especially common with SCLC?

A

Paraneoplastic syndromes are particularly common in SCLC because the cells originate from the diffuse neuroendocrine system (DNES) and may release substances, such as hormones and antibodies.

62
Q

SCLC is not aggressive. True/False

A

False

extremly aggresive, Tumor volume doubling time of 10–50 days

63
Q

SCLC is associated with what mutation?

A

Associated mutations: l-myc

64
Q

what are the principles of management of SCLC?

A
•	STAGE
•	Small cell carcinoma
–	Limited vs extensive stage
–	Chemotherapy
•	Extremely chemosensitive; platinum and Etoposide
–	Radiotherapy
–	Poor survival
•
65
Q

what are the management options for NSCLC

A

Non-small cell carcinoma:
– TNM
• Tumour size, nodal involvement, distant metastases
– Surgery
– Chemotherapy
– Radiotherapy
– Molecular testing for targeted drug therapies
Candidates for surgery: resectable tumor and operable (low risk of postoperative complications based on preoperative evaluation)

66
Q

SCLC can be treated with surgery. True/False

A

False
SCLCs initially respond very well to chemotherapy, but remission only lasts for a short period! Only in very rare cases can patients be healed by surgery!

67
Q

what are the polychemotherapy options for lung cancer?

A
  • -SCC: cisplatin and vinorelbine

- -SCLC: cisplatin and etoposide

68
Q

what is the cisplatin?

A

A first-generation, platinum-based, alkylating agent that prevents replication of tumor cells by causing intrastrand links within DNA. Used to treat bladder, ovarian, and particularly testicular cancer. Adverse effects include nephrotoxicity, peripheral neuropathy, and ototoxicity.

69
Q

what is the vinorelbine?

A

An antineoplastic drug that belongs to the class of vinca alkaloids. Used in the treatment of certain types of breast cancer and non-small cell lung cancer (NSCLC). It works by binding tubulin in microtubules, which causes inhibition of mitosis. Important adverse effects include neutropenia and neurotoxicity.

70
Q

what is the etoposide?

A

A chemotherapeutic agent that inhibits topoisomerase II, which leads to DNA degradation. Commonly used in the treatment of testicular and small cell lung cancer. Adverse effects include myelosuppression and alopecia

71
Q

what agents are used for targeted therapy of lung cancer?

A
  • -EGFR inhibitors (e.g., gefitinib) in advanced-stage NSCLC that is EGFR-positive
  • -ALK tyrosine kinase inhibitors (e.g., crizotinib) in advanced-stage NSCLC that is ALK-positive
72
Q

distant metastases of lung cancer are detected by?

A

PET CT

73
Q

what is the PET?

A

A diagnostic imaging technique that uses a radiotracer to provide information about blood flow and/or metabolic processes in the body. The most common radiotracer used is fluorodeoxyglucose (FDG).

  • -More accurate than CT at differentiating between benign and malignant nodules
  • -Performed prior to biopsy if the CT imaging is inconclusive, particularly for patients with a high probability of malignancy
74
Q

how NSCLC is staged?

A
•	PET CT
–	Distant metastases
–	Nodal involvement
•	EBUS TBNA
–	Assess nodes for involvement by tumour
•	Must define the extent of disease to
–	Assess prognosis
–	Assign appropriate treatment
75
Q

what is the ECOG status?

A

The ECOG performance status is a scale used to assess how a patient’s disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis (e.g. it one of the three components that form the BCLC HCC staging).
–grade 0: fully active, able to carry on all pre-disease performance without restriction
-grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work
–grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours
–grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours
–grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair
grade 5: dead

76
Q

list other lung malignancies except for prumary lung cancers

A
•	Mesothelioma
•	Thymic lesions
–	Thymoma, thymic carcinoma
–	NUT carcinoma
–	Lymphoepithelioma like carcinoma
•	Salivary gland-like tumors
–	Adenoid cystic carcinoma
–	Mucoepidermoid carcinoma
•	Lymphoma
–	B cell lymphoma
–	T cell lymphoma
77
Q

what are the features of carcinoid syndrome?

A
  • Neuroendocrine neoplasm
  • The mean age of presentation is 40 years
  • 5% of pulmonary neoplasms
  • Usually arise in the central, large bronchi, showing intraluminal growth
  • Presentation: hemoptysis (very vascular tumors), cough, recurrent pneumonia (due to proximal obstruction), asymptomatic (incidental finding on CXR)
  • Biopsy: Medium-sized cells, “salt and pepper” chromatin, typical of neuroendocrine tumors, growing in a nested pattern or trabeculae
  • Positive for neuroendocrine immunohistochemical markers (synaptophysin and chromogranin)
  • Prognosis is excellent in typical carcinoid
  • Treatments are by surgical excision
  • Atypical carcinoid tumors have a higher mitotic rate and can be associated with lymph node metastases, but generally have a very good prognosis
  • Only rarely induce carcinoid syndrome
78
Q

lung carcinoid tumors commonly produce carcinoid syndrome.True/False

A

False

Only rarely induce carcinoid syndrome

79
Q

what are the common symptoms of lung carcinoid tumors?

A

Presentation: hemoptysis (very vascular tumors), cough, recurrent pneumonia (due to proximal obstruction), asymptomatic (incidental finding on CXR)

80
Q

what are the features of carcinoid syndrome?

A

–Diarrhea and abdominal cramps
–Cutaneous flushing
–Possible triggers: alcohol consumption, food intake, stress
–In severe cases, may be accompanied by tachycardia and fluctuating blood pressure
–Dyspnea, wheezing (asthma-like attacks)
–Possible weight loss despite normal appetite
Palpitations
–Carcinoid heart disease
Tricuspid insufficiency and/or pulmonary stenosis
Symptoms of right-sided heart failure